Share on StockTwits

MEI Pharma (NASDAQ:MEIP) Director Charles V. Baltic III purchased 2,000 shares of MEI Pharma stock in a transaction dated Monday, June 30th. The shares were purchased at an average price of $6.56 per share, with a total value of $13,120.00. Following the completion of the acquisition, the director now directly owns 17,750 shares in the company, valued at approximately $116,440. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

Shares of MEI Pharma (NASDAQ:MEIP) opened at 6.70 on Friday. MEI Pharma has a one year low of $5.51 and a one year high of $13.98. The stock’s 50-day moving average is $6.22 and its 200-day moving average is $8.13. The company’s market cap is $144.8 million.

MEI Pharma, Inc, formerly Marshall Edwards, Inc, is a development-stage oncology company. The Company is engaged in the development of drugs for the treatment of cancer.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.